|
|
脂联素发挥生物学效应的信号传导机制 |
任超, 张勇, 梁家立, 张波, 郑德志 |
解放军联勤保障部队第九六〇医院心胸外科, 山东 济南 250031 |
|
[1] 何智慧.脂联素调节代谢的作用机制研究[J].生物化工,2021,7(4):142~143,161. [2] 翟鑫,等.老年2型糖尿病合并冠心病患者胰岛素抵抗与脂代谢及脂联素的相关性分析[J].重庆医学,2021,50(15):2539~2543. [3] Arita Y,et al.Paradoxical decrease of an adipose-specific protein,adiponectin,in obesity[J].Biochem Biophys Res Commun,2012,425(3):560~564. [7] Singh P,et al.Differential effects of leptin on adiponectin expression with weight gain versus obesity[J].Int Obes (Lond),2016,40(2):266~274. [4] Cisneros-Zevallos L,W Y,Bang and C.Delgadillo-puga,ellagic acid and urolithins A and B differentially regulate fat accumulation and inflammation in 3T3-L1 adipocytes while not affecting adipogenesis and insulin sensitivity[J].Int Mol Sci,2020,21(6). [5] Tanabe H,et al.Crystal structures of the human adiponectin receptors[J].Nature,2015,520(7547):312~316. [6] Holland W.L,et al.Receptor-mediated activation of ceramidase activity initiates the pleiotropic actions of adiponectin[J].Nat Med,2011,17(1):55~63. [7] Deepa S S,et al.APPL1 mediates adiponectin-induced LKB1 cytosolic localization through the PP2A-PKCzeta signaling pathway[J].Mol Endocrinol,2011,25(10):1773~1185. [8] Ryu J,et al.APPL1 potentiates insulin sensitivity by facilitating the binding of IRS1/2 to the insulin receptor[J].Cell Rep,2014,7(4):1227~1238. [9] Ruan H,L Q Dong.Adiponectin signaling and function in insulin target tissues[J].Mol Cell Biol,2016,8(2):101~109. [10] Chaurasia B,S A Summers.Ceramides - lipotoxic inducers of metabolic disorders[J].Trends Endocrinol Metab,2015,26(10):538~550. [11] Wang Z V,P E Scherer.Adiponectin,the past two decades[J].Mol Cell Biol,2016,8(2):93~100. [12] Vasiliauskaite-Brooks I,et al.Structural insights into adiponectin receptors suggest ceramidase activity[J].Nature,2017,544(7648):120~123. [13] Matsuda K,et al.Positive feedback regulation between adiponectin and T-cadherin impacts adiponectin levels in tissue and plasma of male mice[J].Endocrinology,2015,156(3):934~946. [14] 谭跃,等.老年人高体质指数与血脂参数和脂联素水平相关性分析[J].中国老年保健医学,2021,19(3):40~43. |
[1] |
拜翠莲, 李昭, 史晓玲. 血清APN leptin及8-OHdG水平与小儿癫痫发作及认知损害的关系[J]. 河北医学, 2020, 26(9): 1425-1429. |
[2] |
马旃, 雷海玲, 孙华毅. 老年高血压患者血清UA CK Cys-C APN水平与颈动脉粥样硬化之间的关系[J]. 河北医学, 2020, 26(5): 755-758. |
[3] |
张弢, 于扬, 隋淼, 许静宜, 杨晓辉. 甲亢患者血清瘦素脂联素水平与甲状腺激素和骨代谢指标的关系[J]. 河北医学, 2020, 26(1): 28-32. |
[4] |
胡文华, 王伟伟. 拜糖平联合利拉鲁肽治疗2型糖尿病的疗效 及对血清Hcy APN的影响[J]. 河北医学, 2019, 25(4): 590-593. |
[5] |
江勇, 谭卫林, 韩潞, 刘兵, 韩东兴. 结直肠癌患者血清脂联素瘦素及其受体表达与临床病理参数的关系[J]. 河北医学, 2018, 24(7): 1121-1124. |
[6] |
朱磊, 解德琼, 张臣丽, 吴娅琳. 肾病综合征患者外周血T细胞亚群及血清脂联素水平与患者激素治疗效果的关系[J]. 河北医学, 2017, 23(10): 1646-1648. |
|
|
|
|